In his newsletter, Profits Unlimited, Paul Mampilly has stated that a revolution is about to occur in the medical sector of the global economy. This is due to advances in a particular type of medical technology referred to as precision medicine. Precision medicine relates to the ability to analyze a patient’s DNA, use the information obtained through this analysis, and custom creates an individualized medication in order to treat an individual. Conventional medical technology relies on a one-size-fits-all approach. This has created significant advancements and today many diseases and ailments that were once life-threatening or capable of being treated. However, there are still many diseases that as of right now have no treatment protocol. Precision medicine promises to develop treatments for these currently untreatable diseases. Read more about Paul on Interview.net.
Paul Mampilly is a senior editor for Banyan Hill Publishing Company. Banyan Hill Publishing Company is one of the world’s most respected publications on investment and trading advice. They employ a global network of investment and trading experts in a number of sectors of the economy. Paul Mampilly, in particular, focuses on creating investment advice that is usable by the average everyday investor.
As an investor himself Paul is able to display an astounding level of both personal and business success. He has worked in investment since 1991 whenever he started as an assistant portfolio manager on Wall Street for Bankers Trust. Over the course of his career, he has served in a number of roles on Wall Street including hedge fund manager for a $6 billion firm.
Today he spends most of his time publishing for Banyan Hill Publishing Company and working on his personal blog and newsletter. His recent statements about precision medicine were incredibly bullish about that sector of the medical field. The ability for a physician to custom create medications for the individual has the potential to revolutionize disease treatment completely. Diseases such as Parkinson’s disease, Alzheimer’s disease, and even arthritis could be treated using this method. Meet the experts on Sovereignsociety.com.
The particular company which Paul has recommended individuals invest in and the precision medical field is based out of the Midwestern United States. Its name is Myriad Genetics. This company is not just a personalized medical company but also a diagnostics company. They are able to analyze a person’s genome and test them for potential disease susceptibility as well as give estimates on the likelihood of treatment success for these diseases. Currently Myriad is the leader in the precision medical industry.